Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated with neoadjuvant external beam irradiation, brachytherapy, and 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 and 2003. Four patients died and 4 had disease progression prior to completion of neoadjuvant therapy. Forty-eight patients underwent operative staging and 14 had findings precluding transplantation. Twenty-eight patients underwent transplantation and 6 patients are awaiting transplantation. Three patients died from perioperative complications, and 4 developed recurrent disease 22 to 63 months after transplantation. Actuarial patient survival was 54% at 5 years for all 56 patients, 64% for 48 operatively staged patients, and 84% for 34 patients with negative staging operations. Actuarial survival was 88% at 1 year and 82 % 5 years after transplantation. Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma.

KEYWORDS

Cholangiocarcinoma - liver transplantation - neoadjuvant therapy

REFERENCES

• 1 Carriaga M T, Henson D E. Liver, gallbladder, extrahepatic bile ducts, and pancreas.  Cancer. 1995;  75 171-190
• 2 Jemal A, Murray T, Samuels A et al.. Cancer statistics, 2003.  CA Cancer J Clin. 2003;  53 5-26
• 3 Rosen C B, Nagorney D M. Cholangiocarcinoma complicating primary sclerosing cholangitis.  Semin Liver Dis. 1991;  11 26-30
• 4 Kaya M, de Groen P C, Angulo P et al.. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.  Am J Gastroenterol. 2001;  96 1164-1169
• 5 Bergquist A, Ekbom A, Olsson R et al.. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.  J Hepatol. 2002;  36 321-327
• 6 Ponsioen C Y, Vrouenraets S M, Prawirodirdjo W et al.. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.  Gut. 2002;  51 562-566
• 7 Ammori B J, Jenkins B L, Lim P C et al.. Surgical strategy for cystic diseases of the liver in a western hepatobiliary center.  World J Surg. 2002;  26 462-469
• 8 Nakeeb A, Pitt H A, Sohn T A et al.. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.  Ann Surg. 1996;  224 463-475
• 9 Jarnagin W R, Fong Y, DeMatteo R P et al.. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.  Ann Surg. 2001;  234 507-519
• 10 Kosuge T, Yamamoto J, Shimada K et al.. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.  Ann Surg. 1999;  230 663-671
• 11 Pichlmayr R, Weimann A, Klempnauer J et al.. Surgical treatment in proximal bile duct cancer. A single-center experience.  Ann Surg. 1996;  224 628-638
• 12 Goldstein R M, Stone M, Tillery G W et al.. Is liver transplantation indicated for cholangiocarcinoma?.  Am J Surg. 1993;  166 768-772
• 13 Iwatsuki S, Todo S, Marsh J W et al.. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.  J Am Coll Surg. 1998;  187 358-364
• 14 Jeyarajah D R, Klintmalm G B. Is liver transplantation indicated for cholangiocarcinoma?.  J Hepatobiliary Pancreat Surg. 1998;  5 48-51
• 15 Loinaz C, Abradelo M, Gomez R et al.. Liver transplantation and incidental primary liver tumors.  Transplant Proc. 1998;  30 3301-3302
• 16 Shunzaburo I, Todo S, Marsh J W et al.. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.  J Am Coll Surg. 1998;  187 358-364
• 17 Meyer C G, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients.  Transplantation. 2000;  69 1633-1637
• 18 Jonas S, Kling N, Guckelberger O et al.. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-term results.  Transpl Int. 1998;  11(Suppl 1) S206-S208
• 19 Shimoda M, Farmer D G, Colquhoun S D et al.. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.  Liver Transpl. 2001;  7 1023-1033
• 20 Foo M L, Gunderson L L, Bender C E et al.. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma.  Int J Radiat Oncol Biol Phys. 1997;  39 929-935
• 21 De Vreede I, Steers J L, Burch P A et al.. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.  Liver Transpl. 2000;  6 309-316
• 22 Hasson Z, Gores G J, Rosen C B et al.. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma.  Surg Oncol Clin N Am. 2002;  11 909-921
• 23 Sudan D, DeRoover A, Chinnakotla S et al.. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.  Am J Transplant. 2002;  2 774-779